Risk Factors for Scleroderma: Who's Most at Risk?

Published: Jun 02, 2024

Identifying who is most at risk for developing scleroderma can help in early detection and management of the condition.

Gender and Age

Scleroderma predominantly affects women, with the onset of symptoms typically occurring between the ages of 30 and 50. This gender disparity suggests that hormonal factors may play a role in the disease's development. Understanding these demographics can assist in early screening and intervention strategies.

Genetic Predisposition

While scleroderma is not directly hereditary, certain genetic markers are linked to an increased risk. Family history of autoimmune diseases can also elevate risk. Genetic predisposition plays a subtle role but is significant enough to warrant attention in family medical histories.

Understanding the key risk factors for developing scleroderma, including gender, age, and genetic predisposition, to aid in early detection and management.

Environmental Triggers

Exposure to certain chemicals or infections might trigger scleroderma in susceptible individuals. Occupational hazards, such as working with silica dust or solvents, have been associated with increased risk. Limiting exposure to these environmental factors can be a preventive measure for those at risk.

Frequently Asked Questions

Women aged 30-50 are most affected.

No, but genetic markers can increase risk.

Exposure to chemicals like silica dust may increase risk.

Yes, a family history of autoimmune diseases can elevate risk.

Key Takeaways

Understanding these risk factors can aid in early detection and preventative care for scleroderma.

Get started by assessing your risk factors with Doctronic today.

Related Articles

References

Nihtyanova SI, Sari A, Harvey JC, et al. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis. Arthritis Rheumatol 2020; 72:465.

Denton CP, Hughes M, Gak N, et al. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology (Oxford) 2016; 55:1906.

Always discuss health information with your healthcare provider.